Generic Name and Formulations:
Epoprostenol (as sodium) 0.5mg, 1.5mg; per vial; pwd for IV infusion after reconstitution.
Indications for FLOLAN:
Primary pulmonary hypertension. Pulmonary hypertension due to scleroderma disease in NYHA Class III and Class IV patients who do not respond adequately to conventional therapy.
Give by continuous chronic IV infusion through a central venous catheter. Initially 2 nanograms/kg per min; increase in increments of 2 nanograms/kg per min at ≥15 minute intervals until response achieved or tolerance develops. Dose decreases should be made gradually in 2 nanograms/kg/min decrements at ≥15 minute intervals until dose-limiting effects resolve.
Chronic use with CHF due to severe left ventricular systolic dysfunction. Pulmonary edema.
Avoid abrupt withdrawal or large dose reductions (may cause rebound pulmonary hypertension). Bleeding disorders. Start anticoagulant therapy, unless contraindicated. Monitor BP and heart rate for several hours after dose changes. Pregnancy (Cat.B). Labor & delivery. Nursing mothers.
Potentiated hypotensive effects with diuretics, antihypertensive agents, other vasodilators. Potentiates anticoagulants, antiplatelet agents. May potentiate digoxin (monitor).
Headache, jaw pain, flushing, GI upset, flu-like symptoms, anxiety, dizziness, tachycardia, myalgia.
Vials—1 (w. diluent)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Examining Associations Between Diabetes and Effects on Cognition
- Untreated Depression Common in Women of Childbearing Age
- Incidence of Psychiatric Disorders in Rheumatoid Arthritis
- Effect of Antidepressant Class, Dose on Pediatric Anxiety Disorders